A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)
Clinical trial NCT06924970 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06924970
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.